Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

TBPH Q1 2016 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

TBPHTheravance Biopharma, Inc.

$700M

Q1 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M

Gross Profit

$18M95.8% margin

Operating Income

-$42M-226.2% margin

Net Income

-$42M-229.0% margin

EPS (Diluted)

$-1.10

QoQ Revenue Growth

+372.9%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$27M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$293M

Total Liabilities

$55M

Stockholders' Equity

$239M

Cash & Equivalents

$129M

← FY 2016 All Quarters Q2 2016 →